Evidence map›Paper›PMID 17517657›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations.

ChongFeng Gao, Kyle Furge, Julie Koeman, Karl Dykema, Yanli Su, Mary Lou Cutler, Adam Werts, Pete Haak, George F Vande Woude

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed.

  1. Review
  2. Review
  3. Exploring genome-transcriptome correlations in cancer.Biochemical Society transactions · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Chromosomal instability in adult-type diffuse gliomas.Acta neuropathologica communications · 2022
    Review
  11. Review
  12. The Dynamic Instability of the Aneuploid Genome.Frontiers in cell and developmental biology · 2022
    Review
  13. iScience · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. HNRNPL RestrainsCancers · 2019
    Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

ChongFeng GaoLaboratory of Molecular Oncology, Van Andel Research Institute, 333 Bostwick Avenue, N.E., Grand Rapids, MI 49503, USA.
Kyle Furge
Julie Koeman
Karl Dykema
Yanli Su
Mary Lou Cutler
Adam Werts
Pete Haak
George F Vande Woude

Funding

Role of Ras Effectors in Mammary DifferentiationR01CA090908 · NCI · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI CUTLER, MARY L · 2002 to 2004
$528k
NCI NIH HHS R01 CA090908
6 · The paper itself

Abstract

Chromosome instability and aneuploidy are hallmarks of cancer, but it is not clear how changes in the chromosomal content of a cell contribute to the malignant phenotype. Previously we have shown that we can readily isolate highly proliferative tumor cells and their revertants from highly invasive tumor cell populations, indicating how phenotypic shifting can contribute to malignant progression. Here we show that chromosome instability and changes in chromosome content occur with phenotypic switching. Further, we show that changes in the copy number of each chromosome quantitatively impose a proportional change in the chromosome transcriptome ratio. This correlation also applies to subchromosomal regions of derivative chromosomes. Importantly, we show that the changes in chromosome content and the transcriptome favor the expression of a large number of genes appropriate for the specific tumor phenotype. We conclude that chromosome instability generates the necessary chromosome diversity in the tumor cell populations and, therefore, the transcriptome diversity to allow for environment-facilitated clonal expansion and clonal evolution of tumor cell populations.

Indexed as

Cell Line, TumorCell ProliferationChromosomal InstabilityChromosomes, HumanGene DosageGene Expression Regulation, NeoplasticHumansMutationNeoplasmsPhenotypeTranscription, GeneticUrokinase-Type Plasminogen ActivatorUrokinase-Type Plasminogen Activator

Identifiers

PMID17517657
PMCPMC1885616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.